Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

Tue, 06th Feb 2024 10:05

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Beeks Financial Cloud Group PLC, up 34% at 145.00 pence, 12-month range 81.42p-155.00p. The cloud computing and connectivity provider says it has won a number of competitive tenders in the first half of financial 2024, and now expects trading in financial 2025 to be "significantly" ahead of previous board expectations. Beeks notes that it has signed a USD2.3 million Proximity Cloud expansion contract, as well as a conditional contract with "one of the largest exchange groups globally." Chief Executive Gordon McArthur says: "We continue to progress with the execution of our 'land and expand' strategy, quickly demonstrating the value of our offerings, as evidenced by the significant Proximity Cloud expansion contract announced this morning and the winning of a third major global exchange customer for our Exchange Cloud offering. We see considerable expansion potential across our customers, as they migrate increasing proportions of their trading infrastructure to the cloud."

----------

Fusion Antibodies PLC, up 16% at 5.50p, 12-month range 3.02p-56.00p. Shares in the contract researcher rise. It receives a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company". The follow on project is worth USD650,000. CEO Adrian Kinkaid says: "It is always thrilling and satisfying to share in our clients' successes. We are delighted that the programme has been so productive, and we look forward to continuing to work with our client to bring better antibodies to the clinic more rapidly. The collaborative nature of the project, with creative problem solving from both parties over the full length of the programme, makes this a model example of Fusion's Integrated Therapeutic Antibody Service and highlights the strong reputation that Fusion has for delivering high quality therapeutic antibodies."

----------

AIM - LOSERS

----------

PCI-PAL PLC, down 10% at 49.98p, 12-month range 38.25p-66.70p. Shares in the provider of cloud-based secure payment solutions for business communications fall despite a positive trading update. Revenue in the six months to December 31 rises 20% to GBP8.7 million from GBP7.3 million a year before. Annual recurring revenue in the period increases 23% to GBP14.7 million from GBP11.9 million. Looking ahead, CEO James Barham says: "The start of H2 has seen the group maintain new sales momentum and we continue to focus on delivering the group's profitability objectives, enhancing shareholder value, and capitalising on the strategic opportunities for continued growth."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
28 Nov 2023 10:33

AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
9 Nov 2023 12:54

EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Sep 2023 21:19

EARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widens

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
24 Aug 2023 14:45

Fusion Antibodies appoints interim finance chief

(Sharecast News) - Preclinical antibody developer Fusion Antibodies announced the immediate appointment of Stephen Smyth as its interim chief financial officer on Thursday.

Read more
24 Aug 2023 12:10

IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth as interim chief financial officer with immediate effect. Smyth was previously CFO at Sera Global LP, and has held senior finance positions at Cormark Securities Inc and PricewaterhouseCoopers LLP. He is currently a partner at FPM Accountants Ltd.

Read more
21 Aug 2023 13:43

Fusion Antibodies progresses AI antibody collaboration

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies updated the market on its 'AI/ML-Ab', or AIM-Lab, service on Monday.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:35

Fusion Antibodies inks deal with AI learning firm, hails lower costs

(Alliance News) - Fusion Antibodies PLC on Monday said it signed an agreement with an unnamed artificial intelligence & machine learning company, which it said could cut costs per sequence test significantly.

Read more
14 Aug 2023 08:41

Fusion Antibodies completes "difficult" restructuring

(Alliance News) - Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million.

Read more
1 Jun 2023 15:52

UK shareholder meetings calendar - next 7 days

Friday 2 June 
Cap-XX LtdGM re fundraising
Conduity Capital PLCGM re future direction of the company
Kibo Energy PLCEGM re renewal of director authorisations to issue shares
Mirriad Advertising PLCGM re new ordinary shares admitted to trading on AIM
Purplebricks Group PLCGM re proposed sale of business & assets to Strike Ltd
Monday 5 June 
EnQuest PLCAGM
Tuesday 6 June 
Billington Holdings PLCAGM
Mast Energy Developments PLCAGM
NB Global Monthly Income Fund LtdAGM
Tasty PLCAGM
WANdisco PLCGM re new shares authorisation and fundraise
Wednesday 7 June 
City Pub Group PLCAGM
Gem Diamonds LtdAGM
Gulf Marine Services PLCAGM
Hostmore PLCAGM
LXi REIT PLCAGM
Pennant International Group PLCAGM
Third Point Investors LtdAGM
United Oil & Gas PLCAGM
Xpediator PLCGM re takeover by DLM Bidco
Thursday 8 June 
Ashtead Technology Holdings PLCAGM
Camellia PLCAGM
Checkit PLCAGM
Churchill China PLCAGM
CRH PLCCourt Meeting and EGM re proposal to transfer the company's primary listing to NYSE
Downing Renewables & Infrastructure Trust PLCAGM
Fair Oaks Income LtdAGM
Fusion Antibodies PLCGM re result of retail offer
Genflow Biosciences PLCAGM
Glenveagh Properties PLCAGM
Kavango Resources PLCAGM
Kosmos Energy LtdAGM
Melrose Industries PLCAGM
North American Income Trust PLCAGM
Oriole Resources PLCAGM
Panther Metals PLCAGM
REA Holdings PLCAGM
Renalytix PLCGM re director's authorization to allot new shares and equity securities for cash
Vaalco Energy IncAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 May 2023 11:43

IN BRIEF: Fusion Antibodies shares drop after placing at 84% discount

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Raises GBP1.6 million through a placing and director subscription of 31.2 million shares at 5 pence per share, which is an 84% discount to the stock's close on Thursday of 32.06p. The placing is run by broker Allenby Capital Ltd. Fusion also launches a separate retail offer via the REX platform of up to 10.0 million shares at the same price, to raise up to an additional GBP500,000.

Read more
21 Mar 2023 10:58

Fusion Antibodies files patent application for cancer treatment

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has filed a patent application for a panel of antibodies that bind to an important target for cancer therapeutics.

Read more
6 Mar 2023 16:26

Contract suspensions see Fusion Antibodies warn on revenue

(Sharecast News) - Contract research organisation Fusion Antibodies issued a revenue warning on Monday, after a "challenging" first six months of trading as a number of valuable projects were suspended by clients due to delayed investment.

Read more
6 Mar 2023 12:16

LONDON MARKET MIDDAY: Mining stocks weigh on blue-chip index

(Alliance News) - Stock prices in London were largely lower at midday on Monday, with the FTSE 100 trading in the red, weighed down by poor performances by mining stocks.

Read more
6 Mar 2023 10:52

Fusion Antibodies drops as annual revenue seen significantly lower

(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.